Merck’s Covid Antiviral Gets WHO Backing for High-Risk Patients

Published March 3, 2022

              Merck & Co.’s Covid-19 antiviral pill was endorsed by a World Health Organization panel for patients in the early stages of disease who face high risk of hospitalization.